Ampio Pharmaceuticals, Inc. 4 SEC Filings

Filed On	Filing
13 Jun 2023	Form 4: Buchi J Kevin, Director Bought 21,858 shares ($6.28K)
09 Jun 2023	Form 4: Buchi J Kevin, Director Bought 25,000 shares ($7.4K)
26 May 2023	Form 4: Martino Michael A, Director Bought 76,890 shares ($22.1K)
17 May 2023	Form 4: Buchi J Kevin, Director Bought 32,534 shares ($8.92K)
16 May 2023	Form 4: Buchi J Kevin, Director Bought 23,440 shares ($5.51K) · Bought 44,026 shares ($10.9K)
12 May 2023	Form 4: Stevens David R, Director Bought 50,000 shares ($10.9K) · Bought 45,000 shares ($9.9K)
02 Mar 2022	Form 4: Jobes Elizabeth Varki, Director Granted 150,000 Stock Option (Right to Buy)
10 Feb 2022	Form 4: Bar-Or David, Director Granted 75,000 Stock Option (right to buy)
04 Jan 2022	Form 4: Stokely Dan, CFO Gave up 22,914 shares to cover exercise price or tax ($13.1K)
04 Jan 2022	Form 4: Cherevka Holli, PRESIDENT AND COO Gave up 47,200 shares to cover exercise price or tax ($26.9K)
04 Jan 2022	Form 4: Macaluso Michael, Director Gave up 68,400 shares to cover exercise price or tax ($39K)
03 Jan 2022	Form 4: Martino Michael A, Director Granted 250,000 Stock Option (Right to Buy)
03 Jan 2022	Form 4: Giles Richard B, Director Granted 75,000 Stock Option (Right to Buy)
03 Jan 2022	Form 4: Buchi J Kevin, Director Granted 75,000 Stock Option (Right to Buy)
03 Jan 2022	Form 4: Stevens David R, Director Granted 75,000 Stock Option (Right to Buy)
03 Jan 2022	Form 4: Coelho Philip H, Director Granted 75,000 Stock Option (Right to Buy)
24 Nov 2021	Form 4: Martino Michael A, Director Granted 750,000 Stock Option (Right to Buy)
28 Oct 2021	Form 4: Stokely Dan, CFO Gave up 28,127 shares to cover exercise price or tax ($46.1K)
28 Oct 2021	Form 4: Cherevka Holli, PRESIDENT AND COO Gave up 41,980 shares to cover exercise price or tax ($68.8K)
28 Oct 2021	Form 4: Macaluso Michael, Director Gave up 43,470 shares to cover exercise price or tax ($71.3K)

Comments